Noema Pharma’s Post

Noema Pharma reposted this

Proud to share this exciting news… the 5th P2 program to enter the clinic as we broaden our portfolio of first-in-disease transformational approaches targeting neuroscience based conditions, including women’s health.

Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopause

Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopause

globenewswire.com

Jasper Daniel

Global Commercial Strategy and Digital Innovation.

3mo

This is exciting news, Kavita!! Kudos to the Noema Pharma team for your dedication to advancing healthcare solutions. Looking forward to the outcomes of this study!

Like
Reply

Congratulations kavita

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics